Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 44,539	$ 24,404
Cost of sales	19,505	11,913
Gross profit	25,034	12,491
Operating expenses:
Research and development	13,084	10,737
Selling, general and administrative	39,599	30,131
Total operating expenses	52,683	40,868
Loss from operations	(27,649)	(28,377)
Interest expense	(1,045)	(886)
Interest and other income, net	2,737	779
Net loss	$ (25,957)	$ (28,484)
Net loss per share, basic (in dollars per share)	$ (0.51)	$ (0.63)
Net loss per share, diluted (in dollars per share)	$ (0.51)	$ (0.63)
Weighted-average common shares used to compute net loss per share attributable to
Common shareholders, Basic (in shares)	51,011	45,066
Common shareholders, Diluted (in shares)	51,011	45,066
Other comprehensive loss:
Unrealized gain on cash equivalents	$ 29	$ 21
Comprehensive loss	$ (25,928)	$ (28,463)